Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    January 2024
  1. ALEGRE-AYALA J, Vela-Desojo L, Fernandez-Vazquez D, Navarro-Lopez V, et al
    Motor and process skills of people with parkinson's disease compared to healthy older adults. A cross-sectional study.
    Rev Neurol. 2024;78:31-39.
    PubMed     Abstract available


    December 2023
  2. GELDRES-PALOMINO AN, Poma-Barrientos MIY
    [Occupational performance skills in Parkinson's disease: relationship with health-related quality of life and caregiver burden. Letter].
    Rev Neurol. 2023;77:305.
    PubMed    


    October 2023
  3. MORALES-CASADO MI, Garcia-Melendez DD, Diezma-Martin A, Lopez-Ariztegui N, et al
    Effectiveness and safety of safinamide in the Toledo Movement Disorders Unit.
    Rev Neurol. 2023;77.
    PubMed     Abstract available


  4. KULISEVSKY J, Esquivel A, Freire-Alvarez E, Gomez-Esteban JC, et al
    SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.
    Rev Neurol. 2023;77.
    PubMed     Abstract available


  5. FERNANDEZ-PAJARIN G, Ares-Pensado B, Koukoulis A, Jimenez-Martin I, et al
    [Subthalamic deep brain stimulation in a case of idiopathic Parkinson's disease and schizophrenia].
    Rev Neurol. 2023;77:167-170.
    PubMed     Abstract available


    September 2023
  6. FERNANDEZ-VAZQUEZ D, Molina-Rueda F, Navarro-Lopez V, Straudi S, et al
    Muscle strength and spatiotemporal gait parameters in people with Parkinson s disease. A pilot study.
    Rev Neurol. 2023;77:115-124.
    PubMed     Abstract available


    August 2023
  7. CAMPINS-ROMEU M, Sastre-Bataller I, Conde-Sardon R, Baviera-Munoz R, et al
    Combined subthalamic nucleus and globus pallidus internus deep brain stimulation in Parkinson's disease.
    Rev Neurol. 2023;77:83-86.
    PubMed     Abstract available


  8. TREJO-GABRIEL-GALAN JM, Cubo-Delgado E
    [Telephone assistance for neurological diseases: a systematic review].
    Rev Neurol. 2023;77:67-73.
    PubMed     Abstract available


    July 2023
  9. ALEGRE-AYALA J, Vela-Desojo L, Fernandez-Vazquez D, Navarro-Lopez V, et al
    Occupational performance skills in Parkinson's disease: relationship with health-related quality of life and caregiver burden.
    Rev Neurol. 2023;77:3-11.
    PubMed     Abstract available


    April 2023
  10. ALEGRE-AYALA J, Vela L, Fernandez-Vazquez D, Navarro-Lopez V, et al
    The impact of Parkinson's disease severity on performance of activities of daily living: an observational study.
    Rev Neurol. 2023;76:249-255.
    PubMed     Abstract available


    March 2023
  11. SANCHEZ-CARDENAS MA, Sanchez-Rua M, Sequea-Torregrosa L, Ramirez-Zapata D, et al
    [Palliative care for people with advanced Parkinson's disease. A systematic review].
    Rev Neurol. 2023;76:167-175.
    PubMed     Abstract available


    January 2023
  12. VALENCIA-VASQUEZ A, Gaviria-Mendoza A, Ayala-Torres JD, Calvo-Torres F, et al
    Time until modification of antiparkinsonian therapy in a group of patients from Colombia.
    Rev Neurol. 2023;76:1-8.
    PubMed     Abstract available


    October 2022
  13. KULISEVSKY J
    Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.
    Rev Neurol. 2022;75.
    PubMed     Abstract available


    June 2022
  14. FERNANDEZ-PAJARIN G, Martin-Jimenez I, Ares-Pensado B, Sesar-Ignacio A, et al
    [Apomorphine and frontal dysfunction in Parkinson's disease].
    Rev Neurol. 2022;74:367-371.
    PubMed     Abstract available


    May 2022
  15. MELENDEZ-FLORES JD, Irabien-Zuniga M, Cerda-Contreras C, de Los Reyes-Calderon I, et al
    [Parkinson's disease phenotype based on age at onset in Latin American patients: a paired-based analysis].
    Rev Neurol. 2022;74:298-302.
    PubMed     Abstract available


    March 2022
  16. CAMPINS-ROMEU M, Sastre-Bataller I, Pons-Beltran V, Baviera-Munoz R, et al
    [Adverse effects and complications of continuous intestinal infusion of levodopa-carbidopa in a cohort of patients with Parkinson's disease in a tertiary hospital].
    Rev Neurol. 2022;74:143-148.
    PubMed     Abstract available


    February 2022
  17. AREVALO-SAENZ A, Lopez-Manzanares L, Navas-Garcia M, Pastor J, et al
    Deep brain stimulation in Parkinson's disease: analysis of brain fractional anisotropy differences in operated patients.
    Rev Neurol. 2022;74:125-134.
    PubMed     Abstract available


    December 2021
  18. LOPEZ-ARIZTEGUI N, Mata-Alvarez Santullano M, Tegel I, Almeida F, et al
    [Opicapone for the treatment of Parkinson's disease: real-life data in Spain].
    Rev Neurol. 2021;73.
    PubMed     Abstract available


    November 2021
  19. CAMPO-PRIETO P, Santos-Garcia D, Cancela-Carral JM, Rodriguez-Fuentes G, et al
    [Current status of immersive virtual reality as a tool for physical and functional rehabilitation in patients with Parkinson s disease: systematic review].
    Rev Neurol. 2021;73:358-367.
    PubMed     Abstract available


    May 2021
  20. ALONSO-CANOVAS A, Martinez-Castrillo JC
    [Apomorphine: a powerful ally in Parkinson's disease].
    Rev Neurol. 2021;72:323-332.
    PubMed     Abstract available


    April 2021
  21. GONZALEZ-CASTRO A, Rodriguez-Rodriguez E, Arnaiz F, Ferrer-Pargada D, et al
    [Peripheral facial paralysis in patients with SARS-CoV-2 in prono position].
    Rev Neurol. 2021;72:296-297.
    PubMed    


  22. MUNOZ-SALGADO M, Del Rio D
    [Object and action naming in a sentence context in people with Parkinson's disease free of dementia].
    Rev Neurol. 2021;72:223-230.
    PubMed     Abstract available


    March 2021
  23. MANEZ-MIRO JU, Vivancos-Matellano F, Wetmore J, Martinez-Martin P, et al
    [Pilot study of a new tool to optimise dopaminergic treatment in Parkinson's disease: the OPTIMIPARK questionnaire].
    Rev Neurol. 2021;72:179-186.
    PubMed     Abstract available


  24. AGUILAR-AGUDO A, Herruzo-Cabrera J, Pino-Osuna MJ
    [Protective and risk factors predicting caregiver psychological distress in people with advanced Parkinson's disease].
    Rev Neurol. 2021;72:145-150.
    PubMed     Abstract available


    January 2021
  25. MELENDEZ-FLORES JD, Castillo-Torres SA, Cerda-Contreras C, Chavez-Luevanos B, et al
    Clinical features of metabolic syndrome in patients with Parkinson's disease.
    Rev Neurol. 2021;72:9-15.
    PubMed     Abstract available


  26. AVILA A, Pastor P, Planellas L, Gil-Villar MP, et al
    [DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia].
    Rev Neurol. 2021;72:1-8.
    PubMed     Abstract available


    December 2020
  27. BRANDIN-DE LA CRUZ N, Secorro N, Calvo S, Benyoucef Y, et al
    Immersive virtual reality and antigravity treadmill training for gait rehabilitation in Parkinson's disease: a pilot and feasibility study.
    Rev Neurol. 2020;71:447-454.
    PubMed     Abstract available


  28. RODRIGUEZ-SANZ A, Pena-Llamas E, Alonso-Canovas A, Alonso-Frech FA, et al
    [Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].
    Rev Neurol. 2020;71:407-420.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.